Kudchadkar R, Chang ALS. Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S47. Available from: https://jofskin.org/index.php/skin/article/view/303